Accumulating evidence suggests that PFKFB4 plays a crucial role in glycolytic metabolism, cancer stemness, and hypoxic adaptation [56–58], providing potential mechanistic insights into lenvatinib resistance. Here, PFKFB4 is linked to cancer.